Atyr Pharma Inc (NASDAQ:ATYR) has a beta value of 0.95 and has seen 3.68 million shares traded in the last trading session. The company, currently valued at $492.19M, closed the last trade at $5.53 per share which meant it gained $0.23 on the day or 4.34% during that session. The ATYR stock price is -8.14% off its 52-week high price of $5.98 and 71.43% above the 52-week low of $1.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.63 million shares traded. The 3-month trading volume is 2.34 million shares.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Sporting 4.34% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ATYR stock price touched $5.53 or saw a rise of 1.07%. Year-to-date, Atyr Pharma Inc shares have moved 229.17%, while the 5-day performance has seen it change 4.34%. Over the past 30 days, the shares of Atyr Pharma Inc (NASDAQ:ATYR) have changed 2.50%. Short interest in the company has seen 13.64 million shares shorted with days to cover at 6.12.

Atyr Pharma Inc (ATYR) estimates and forecasts

The company’s shares have gained 47.86% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.28% over the past 5 years.

ATYR Dividends

Atyr Pharma Inc is expected to release its next earnings report on 2025-May-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders

Insiders own 2.23% of the company shares, while shares held by institutions stand at 69.63% with a share float percentage of 71.22%. Investors are also buoyed by the number of investors in a company, with Atyr Pharma Inc having a total of 103.0 institutions that hold shares in the company.